The clinical investigations showed that 177 CRC patients with high expression of LINC00152 and FSCN1 had the worst prognosis, while if either LINC00152 or FSCN1 was downregulated; the prognosis was improved. This evidence concerns the gene FSCN1 and colorectal carcinoma.